Skip to main content

CORRECTION article

Front. Immunol., 04 May 2022
Sec. Cancer Immunity and Immunotherapy
Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.909105
This article is part of the Research Topic Reprogramming the Cellular, Molecular and Metabolic Architecture of the Tumor Microenvironment for Effective Cancer Immunotherapy View all 17 articles

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

This article is a correction to:

  1. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

    1. Read original article
Mingchuang Zhu&#x;Mingchuang Zhu1†Qingpeng Zeng&#x;Qingpeng Zeng2†Tao FanTao Fan1Yuanyuan LeiYuanyuan Lei2Feng WangFeng Wang2Sufei ZhengSufei Zheng2Xinfeng WangXinfeng Wang2Hui ZengHui Zeng2Fengwei TanFengwei Tan2Nan SunNan Sun2Qi XueQi Xue2Jie He,*Jie He1,2*
  • 1Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China
  • 2National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

A Corrigendum on
Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

By Zhu M, Zeng Q, Fan T, Lei Y, Wang F, Zheng S, Wang X, Zeng H, Tan F, Sun N, Xue Q and He J (2022) Front. Immunol. 13:783495. doi: 10.3389/fimmu.2022.783495

In the published article, there was an error regarding the affiliations for author Jie He. As well as having affiliation 2, he should also have affiliation 1.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

A correction has been made to the Abstract, subsection Background, paragraph one:

In the original article, there was an error. The sentence “The early-stage lung adenocarcinoma (LUAD) incidence has increased with heightened public awareness and lung cancer screening implementation” has been corrected to

“The early-stage lung adenocarcinoma (LUAD) rate has increased with heightened public awareness and lung cancer screening implementation.”

A correction has been made to the Introduction, paragraph one:

In the original article, there was an error. The sentence “The incidence of early-stage LUAD has increased rapidly with heightened public awareness and implementation of lung cancer screening” has been corrected to

“The rate of early-stage LUAD has increased rapidly with heightened public awareness and implementation of lung cancer screening”.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: lipid metabolism, early-stage lung adenocarcinoma (LUAD), recurrence, immune checkpoints(ICP), signature

Citation: Zhu M, Zeng Q, Fan T, Lei Y, Wang F, Zheng S, Wang X, Zeng H, Tan F, Sun N, Xue Q and He J (2022) Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis. Front. Immunol. 13:909105. doi: 10.3389/fimmu.2022.909105

Received: 31 March 2022; Accepted: 21 April 2022;
Published: 04 May 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Zhu, Zeng, Fan, Lei, Wang, Zheng, Wang, Zeng, Tan, Sun, Xue and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jie He, prof.jiehe@gmail.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.